Home

Trêve famille jauge kras colon cancer Le jour du professeur Botaniste Radioactif

APMG Colon Molecular Pathways
APMG Colon Molecular Pathways

Differential Reprogramming of Isogenic Colorectal Cancer Cells by Distinct  Activating KRAS Mutations | Journal of Proteome Research
Differential Reprogramming of Isogenic Colorectal Cancer Cells by Distinct Activating KRAS Mutations | Journal of Proteome Research

The current understanding on the impact of KRAS on colorectal cancer -  ScienceDirect
The current understanding on the impact of KRAS on colorectal cancer - ScienceDirect

Study reveals potential target for precision colorectal cancer treatment -  Redox Medicine Society
Study reveals potential target for precision colorectal cancer treatment - Redox Medicine Society

Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal  cancer | Molecular Cancer | Full Text
Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer | Molecular Cancer | Full Text

Immune modulatory effects of oncogenic KRAS in cancer | Nature  Communications
Immune modulatory effects of oncogenic KRAS in cancer | Nature Communications

Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal  cancer | Molecular Cancer | Full Text
Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer | Molecular Cancer | Full Text

Prevalence of KRAS, NRAS and BRAF mutations in patients with colorectal...  | Download Scientific Diagram
Prevalence of KRAS, NRAS and BRAF mutations in patients with colorectal... | Download Scientific Diagram

TAK1 Inhibition Promotes Apoptosis in KRAS-Dependent Colon Cancers -  ScienceDirect
TAK1 Inhibition Promotes Apoptosis in KRAS-Dependent Colon Cancers - ScienceDirect

Progress towards individualized treatment of colorectal cancer UAB Barcelona
Progress towards individualized treatment of colorectal cancer UAB Barcelona

Frequencies of KRAS mutations measured using methods with different... |  Download Scientific Diagram
Frequencies of KRAS mutations measured using methods with different... | Download Scientific Diagram

The Prognostic Impact of KRAS G12C Mutation in Patients with Metastatic Colorectal  Cancer: A Multicenter Retrospective Observational Study - Chida - 2021 -  The Oncologist - Wiley Online Library
The Prognostic Impact of KRAS G12C Mutation in Patients with Metastatic Colorectal Cancer: A Multicenter Retrospective Observational Study - Chida - 2021 - The Oncologist - Wiley Online Library

Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of  cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal  cancer: a retrospective consortium analysis - The Lancet Oncology
Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis - The Lancet Oncology

Can KRAS Positive Colorectal and Lung Cancer Finally be Targeted? -  CancerConnect
Can KRAS Positive Colorectal and Lung Cancer Finally be Targeted? - CancerConnect

KRAS and extended RAS molecular profiling in metastatic colorectal cancer | Colorectal  Cancer
KRAS and extended RAS molecular profiling in metastatic colorectal cancer | Colorectal Cancer

IJMS | Free Full-Text | Gene Therapy Targeting p53 and KRAS for Colorectal  Cancer Treatment: A Myth or the Way Forward?
IJMS | Free Full-Text | Gene Therapy Targeting p53 and KRAS for Colorectal Cancer Treatment: A Myth or the Way Forward?

Kras in metastatic colorectal cancer
Kras in metastatic colorectal cancer

KRAS mutation: from undruggable to druggable in cancer | Signal  Transduction and Targeted Therapy
KRAS mutation: from undruggable to druggable in cancer | Signal Transduction and Targeted Therapy

Chemically modified MIR143-3p exhibited anti-cancer effects by impairing  the KRAS network in colorectal cancer cells: Molecular Therapy - Nucleic  Acids
Chemically modified MIR143-3p exhibited anti-cancer effects by impairing the KRAS network in colorectal cancer cells: Molecular Therapy - Nucleic Acids

Life | Free Full-Text | Integrated Decision-Making in the Treatment of Colon-Rectal  Cancer: The Case of KRAS-Mutated Tumors
Life | Free Full-Text | Integrated Decision-Making in the Treatment of Colon-Rectal Cancer: The Case of KRAS-Mutated Tumors

Therapeutic strategy in unresectable metastatic colorectal cancer: an  updated review - Benoist Chibaudel, Christophe Tournigand, Franck  Bonnetain, Hubert Richa, Magdalena Benetkiewicz, Thierry André, Aimery de  Gramont, 2015
Therapeutic strategy in unresectable metastatic colorectal cancer: an updated review - Benoist Chibaudel, Christophe Tournigand, Franck Bonnetain, Hubert Richa, Magdalena Benetkiewicz, Thierry André, Aimery de Gramont, 2015

Colorectal Cancer
Colorectal Cancer

Integrated multi-omics characterization of KRAS mutant colorectal cancer
Integrated multi-omics characterization of KRAS mutant colorectal cancer

The Trouble With KRAS - Cancer Commons
The Trouble With KRAS - Cancer Commons

Frontiers | Prognostic and therapeutic impact of the KRAS G12C mutation in colorectal  cancer
Frontiers | Prognostic and therapeutic impact of the KRAS G12C mutation in colorectal cancer

Mutations in APC, Kirsten-ras, and p53—alternative genetic pathways to colorectal  cancer | PNAS
Mutations in APC, Kirsten-ras, and p53—alternative genetic pathways to colorectal cancer | PNAS

Tumor microenvironment-adjusted prognostic implications of the KRAS  mutation subtype in patients with stage III colorectal cancer treated with  adjuvant FOLFOX | Scientific Reports
Tumor microenvironment-adjusted prognostic implications of the KRAS mutation subtype in patients with stage III colorectal cancer treated with adjuvant FOLFOX | Scientific Reports